Hamouda Nahla, Sano Tatsushi, Oikawa Yosuke, Ozaki Toru, Shimakawa Masaki, Matsumoto Kenjiro, Amagase Kikuko, Higuchi Kazuhide, Kato Shinichi
Division of Pathological Sciences, Department of Pharmacology and Experimental Therapeutics, Kyoto Pharmaceutical University, Kyoto, Japan.
Second Department of Internal Medicine, Osaka Medical College, Takatsuki, Osaka, Japan.
Basic Clin Pharmacol Toxicol. 2017 Sep;121(3):159-168. doi: 10.1111/bcpt.12793. Epub 2017 May 10.
The chemotherapeutic agent 5-fluorouracil (5-FU) causes intestinal mucositis with severe diarrhoea, but the pathogenesis is not fully understood. In this study, we investigated the pathogenic effects of 5-FU in mice, focusing on apoptosis, enterobacteria and inflammatory cytokines. Repeated administration of 5-FU caused severe intestinal mucositis on day 6, accompanied by diarrhoea and body-weight loss. TNF-α expression increased 1 day after exposure to the drug, and spiked a second time on day 4, at which point myeloperoxidase activity and IL-1β expression also increased. Apoptotic cells were observed in intestinal crypts only on day 1. 5-FU also induced dysbiosis, notably decreasing the abundance of intestinal Firmicutes while increasing the abundance of Bacteroidetes and Verrucomicrobia. Twice-daily co-administration of oral antibiotics significantly reduced the severity of intestinal mucositis and dysbiosis, and blocked the increase in myeloperoxidase activity and cytokine expression on day 6, without affecting apoptosis and TNF-α up-regulation on day 1. In cultured colonic epithelial cells, exposure to 5-FU also up-regulated TNF-α expression. Collectively, the data suggest that crypt apoptosis, dysbiosis and expression of inflammatory cytokines are sequential events in the development of intestinal mucositis after exposure to 5-FU. In particular, 5-FU appears to directly induce apoptosis via TNF-α and to suppress intestinal cell proliferation, thereby resulting in degradation of the epithelial barrier, as well as in secondary inflammation mediated by inflammatory cytokines.
化疗药物5-氟尿嘧啶(5-FU)可导致肠道粘膜炎并伴有严重腹泻,但其发病机制尚未完全明确。在本研究中,我们以细胞凋亡、肠道细菌和炎性细胞因子为重点,研究了5-FU对小鼠的致病作用。重复给予5-FU在第6天导致严重的肠道粘膜炎,伴有腹泻和体重减轻。接触该药物1天后肿瘤坏死因子-α(TNF-α)表达增加,并在第4天再次飙升,此时髓过氧化物酶活性和白细胞介素-1β(IL-1β)表达也增加。仅在第1天在肠道隐窝中观察到凋亡细胞。5-FU还诱导了菌群失调,显著降低了肠道厚壁菌门的丰度,同时增加了拟杆菌门和疣微菌门的丰度。每日两次联合口服抗生素可显著减轻肠道粘膜炎和菌群失调的严重程度,并在第6天阻止髓过氧化物酶活性和细胞因子表达的增加,而不影响第1天的细胞凋亡和TNF-α上调。在培养的结肠上皮细胞中,接触5-FU也上调了TNF-α表达。总体而言,数据表明,隐窝细胞凋亡、菌群失调和炎性细胞因子表达是接触5-FU后肠道粘膜炎发展过程中的连续事件。特别是,5-FU似乎通过TNF-α直接诱导细胞凋亡并抑制肠道细胞增殖,从而导致上皮屏障降解以及炎性细胞因子介导的继发性炎症。
Am J Physiol Gastrointest Liver Physiol. 2012-3-8
Front Cell Infect Microbiol. 2017-10-26
Cancer Chemother Pharmacol. 2010-9-16
Basic Clin Pharmacol Toxicol. 2017-7-25
Cancer Chemother Pharmacol. 2010-12-14
Probiotics Antimicrob Proteins. 2024-12-6
World J Gastrointest Oncol. 2024-8-15